CSIMarket Company Name, Ticker, Industry, else..


Moonlake Immunotherapeutics  (NASDAQ: MLTX)
Other Ticker:  
 

Moonlake Immunotherapeutics

MLTX's Fundamental analysis



Moonlake Immunotherapeutics's sales fell in III. Quarter 2024 from the same quarter a year ago.

Major Pharmaceutical Preparations industry recorded growth of revenues by 9.75 %

Moonlake Immunotherapeutics net loss increased from $-12 millions, to $-36 millions in III. Quarter 2024,

• More on MLTX's Growth


Moonlake Immunotherapeutics
realized a net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 50.87 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.07.


• More on MLTX's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 7.88

Moonlake Immunotherapeutics
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 50.87 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.07.

Moonlake Immunotherapeutics Price to Book Ratio is at 5.9 lower than Industry Avg. of 84.52. and higher than S&P 500 Avg. of 0.01

• More on MLTX's Valuation

•  Market Capitalization (Millions $) 2,925
•  Shares Outstanding (Millions) 63
•  Employees 23
•  Revenues (TTM) (Millions $) -
•  Net Income (TTM) (Millions $) -83
•  Cash Flow (TTM) (Millions $) 57
•  Capital Exp. (TTM) (Millions $) -1
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ -
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) 7.88

•  Market Capitalization (Millions $) 2,925
•  Shares Outstanding (Millions) 63
•  Employees 23
•  Revenues (TTM) (Millions $) -
•  Net Income (TTM) (Millions $) -83
•  Cash Flow (TTM) (Millions $) 57
•  Capital Exp. (TTM) (Millions $) -1





  Ratio
•   Capital Ratio (MRQ) 25.51
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.06
•  Asset Turnover Ratio (TTM) -
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com